Humoral and cellular immune response against tetanus and diphtheria following booster vaccination

Trial Profile

Humoral and cellular immune response against tetanus and diphtheria following booster vaccination

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs DTaP poliovirus vaccine (Primary) ; DTaP vaccine
  • Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Registrational
  • Most Recent Events

    • 09 Jul 2011 Based on the results from this trial, the vaccine was approved by the US FDA for use in subjects aged 65 years or older.
    • 02 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top